المؤلفون: Gabriel Lopez, Amy Spelman, Alejandro Chaoul, Yousra Hashmi, Michael Spano, Qi Wei, Lorenzo Cohen, M. Kay Garcia

المصدر: Integrative Cancer Therapies
Integrative Cancer Therapies, Vol 17 (2018)

مصطلحات موضوعية: integrative medicine, Adult, Male, medicine.medical_specialty, Adolescent, Acupuncture Therapy, Symptom assessment, inpatient, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Neoplasms, Acupuncture, Medicine, cancer, Humans, 030212 general & internal medicine, RC254-282, Research Articles, Aged, Aged, 80 and over, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, Middle Aged, medicine.disease, 3. Good health, Hospitalization, Complementary and alternative medicine, 030220 oncology & carcinogenesis, oncology, Physical therapy, Female, Integrative medicine, business, Symptom score, acupuncture

الوصف: Background: Use of complementary and integrative therapies is increasing among cancer patients, but data regarding the impact treatments such as acupuncture have in an inpatient oncology setting are limited. Methods: Patients who received acupuncture in an inpatient hospital environment between December 2014 and December 2015 were asked to complete a modified Edmonton Symptom Assessment Scale (ESAS; 0-10 scale) before and after each visit. Pre- and post-treatment scores were examined for each symptom using paired t tests. Results: A total of 172 inpatients were treated with acupuncture in their hospital beds (257 visits). Thirty percent (n = 51) received at least one additional follow-up treatment (mean visits/patient = 1.5). Completion rate of the modified ESAS after acupuncture was 42%. The most common reasons for not completing the post-treatment ESAS were “patient too drowsy” or “patient fell asleep” (72%). For patients who reported a baseline symptom score ≥1, the greatest improvements (mean change ± SD) after acupuncture on the initial visit were found for pain (−1.8 ± 2.2; n = 69; P < .0001), nausea (−1.2 ± 1.9; n = 30; P < .001), anxiety (−0.8 ± 1.8; n = 36; P = .01), drowsiness (−0.6 ± 1.8; n = 57; P = .02), and fatigue (−0.4 ± 1.1; n = 67; P = .008). For patients who received at least one follow-up visit, significant improvement from baseline was found for sleep disturbance (−2.5 ± 4.4; n = 17; P = .03), anxiety (−2.4 ± 1.7; n = 9; P = .002), pain (−2.3 ± 2.7; n = 20; P = .001), and drowsiness (−2.0 ± 2.6; n = 16; P = .008). Conclusions: Patients who received inpatient acupuncture at a major cancer center experienced significant improvement after treatment for pain, sleep disturbance, anxiety, drowsiness, nausea, and fatigue.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463ce12ef5e5fc8dab4d584d1f755d9b
http://europepmc.org/articles/PMC5950949

المؤلفون: Aiham Qdaisat, Akhila Reddy, Eduardo Bruera, Gabriel Lopez, Susan Underwood, Shouhao Zhou, Santhosshi Narayanan, Lorenzo Cohen, Wenli Liu, Ying Guo, Sai Ching Yeung, M. Kay Garcia, Michael Spano

المصدر: Integrative Cancer Therapies, Vol 18 (2019)
Integrative Cancer Therapies

مصطلحات موضوعية: integrative medicine, Male, medicine.medical_specialty, Treatment response, Acupuncture Therapy, Traditional Chinese medicine, lcsh:RC254-282, hot flashes, traditional Chinese medicine, 03 medical and health sciences, 0302 clinical medicine, complementary health approaches, Neoplasms, Internal medicine, medicine, Acupuncture, cancer, Humans, 030212 general & internal medicine, Medicine, Chinese Traditional, Retrospective Studies, business.industry, Cancer, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, Complementary and alternative medicine, Oncology, 030220 oncology & carcinogenesis, Female, Integrative medicine, business, Research Article

الوصف: Background: Acupuncture is a recognized integrative modality for managing hot flashes. However, data regarding predictors for response to acupuncture in cancer patients experiencing hot flashes are limited. We explored associations between patient characteristics, including traditional Chinese medicine (TCM) diagnosis, and treatment response among cancer patients who received acupuncture for management of hot flashes. Methods: We reviewed acupuncture records of cancer outpatients with the primary reason for referral listed as hot flashes who were treated from March 2016 to April 2018. Treatment response was assessed using the hot flashes score within a modified Edmonton Symptom Assessment Scale (0-10 scale) administered immediately before and after each acupuncture treatment. Correlations between TCM diagnosis, individual patient characteristics, and treatment response were analyzed. Results: The final analysis included 558 acupuncture records (151 patients). The majority of patients were female (90%), and 66% had breast cancer. The median treatment response was a 25% reduction in the hot flashes score. The most frequent TCM diagnosis was qi stagnation (80%) followed by blood stagnation (57%). Older age ( P = .018), patient self-reported anxiety level ( P = .056), and presence of damp accumulation in TCM diagnosis ( P = .047) were correlated with greater hot flashes score reduction. Conclusions: TCM diagnosis and other patient characteristics were predictors of treatment response to acupuncture for hot flashes in cancer patients. Future research is needed to further explore predictors that could help tailor acupuncture treatments for these patients.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d015e127892fe131bb46cdee3f027de
https://doaj.org/article/4d74fb5f06a24279ade84d65615d072d

المؤلفون: Larry C. Driver, Lorenzo Cohen, Richard T. Lee, Moshe Frenkel, Robin Haddad, J. Lynn Palmer, Qi Wei, M. Kay Garcia

المصدر: Integrative Cancer Therapies. 13:133-140

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Acupuncture Therapy, Alternative medicine, Pain, Pilot Projects, law.invention, Randomized controlled trial, Pain control, law, Neoplasms, Acupuncture, Humans, Pain Management, Medicine, Aged, Aged, 80 and over, business.industry, Symptom management, Cancer, Middle Aged, medicine.disease, Complementary and alternative medicine, Oncology, Uncontrolled pain, Physical therapy, Female, Integrative medicine, business

الوصف: Purpose. Pain control is an ongoing challenge in the oncology setting. Prior to implementing a large randomized trial at our institution, we investigated the feasibility, safety, and initial efficacy of acupuncture for uncontrolled pain among cancer patients. Hypotheses. Our hypotheses were that the acupuncture treatments provided would be ( a) feasible, ( b) safe, and ( c) a beneficial adjunct to pain management. Study Design. This was a single arm, nonrandomized pragmatic pilot study. Methods. Participants experiencing pain ≥4 on a 0 to 10 numeric rating scale received a maximum of 10 treatments on an individualized basis. Recruitment, attrition, compliance, and adverse events (AEs) were assessed. Pain (Brief Pain Inventory–Short Form), quality of life (MD Anderson Symptom Inventory [MDASI]), and patient satisfaction were assessed at baseline and at the end of treatment. Results. Of 115 patients screened, 52 (45%) were eligible and agreed to participate. Eleven (21%) were lost to follow-up, leaving 41 who completed all study procedures. No AEs were reported. Mean pain severity was 6.0 ± 1.3 at baseline and 3.8 ± 2.0 at follow-up ( P < .0001). Pain interference was 6.2 ± 2.3 at baseline and 4.3 ± 2.8 at follow-up ( P < .0011). On the MDASI, the mean symptom severity was 4.6 ± 1.8 at baseline and 3.2 ± 1.9 at follow-up ( P < .0001), and mean symptom interference was 5.8 ± 2.4 at baseline and 4.1 ± 2.9 at follow-up ( P < .002). Prescribed pain medications decreased across the course of the study. Patient satisfaction was high: 87% reported that their expectations were met “very well” or “extremely well”; 90% said they were likely to participate again; 95% said they were likely to recommend acupuncture to others; and 90% reported they found the service to be “useful” or “very useful.” Conclusions. Acupuncture was feasible, safe, and a helpful treatment adjunct for cancer patients experiencing uncontrolled pain in this study. Randomized placebo-controlled trials are needed to confirm these results.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c7fce32b5a9950de304b834885ebae
https://doi.org/10.1177/1534735413510558